Industry News
NORA Welcomes New Leadership to Advance Neuro-Optometric Rehabilitation Initiatives

In a recent announcement, the Neuro-Optometric Rehabilitation Association, International (NORA) anno...

read more
NORA Welcomes New Leadership to Advance Neuro-Optometric Rehabilitation Initiatives
December 01, 2023
Delhi Witnesses 40% Surge in Eye Diseases Due to High Level of Air Pollution

Ophthalmologists in Delhi are witnessing a concerning surge in patients grappling with eye issues su...

read more
Delhi Witnesses 40% Surge in Eye Diseases Due to High Level of Air Pollution
November 29, 2023
VSY Biotechnology Showcases Novel Enova Advanced EDoF IOL at EPOMEC 2023

VSY Biotechnology, a leading company in ophthalmic innovations, made a notable presence at the 10th ...

read more
VSY Biotechnology Showcases Novel Enova Advanced EDoF IOL at EPOMEC 2023
November 28, 2023
10th EPOMEC 2023: A Premier Hub for Ophthalmic Knowledge in the Middle East

The 10th Evolving Practice of Ophthalmology Middle East Conference (EPOMEC 2023) is set to illuminat...

read more
10th EPOMEC 2023: A Premier Hub for Ophthalmic Knowledge in the Middle East
November 24, 2023
Emily Chew, MD, Recognized as NIH Distinguished Investigator

Emily Chew, MD, has recently been elevated to the esteemed position of NIH Distinguished Investigato...

read more
Emily Chew, MD, Recognized as NIH Distinguished Investigator
November 24, 2023
Genentech and Nvidia Form AI Research Collaboration for Drug Discovery and Development

Genentech announced a multi-year strategic research collaboration with Nvidia in an effort to expedi...

read more
Genentech and Nvidia Form AI Research Collaboration for Drug Discovery and Development
November 22, 2023
Oxurion Files for Bankruptcy after Phase 2 Clinical Trial for DME Drug Fails

Oxurion initiated the bankruptcy filing process following the unsuccessful Phase IIb trial of its di...

read more
Oxurion Files for Bankruptcy after Phase 2 Clinical Trial for DME Drug Fails
November 21, 2023
Inflammasome Therapeutics Gets FDA Nod for Dry AMD Clinical Trial

Inflammasome Therapeutics announced that the FDA has given approval for the opening of a phase 1/2 c...

read more
Inflammasome Therapeutics Gets FDA Nod for Dry AMD Clinical Trial
November 20, 2023
EyeBio Secures $130 Million to Accelerate Development of Restoret

EyeBio announced the successful completion of an extension to its Series A financing, resulting in a...

read more
EyeBio Secures $130 Million to Accelerate Development of Restoret
November 17, 2023
Keeler and Long Grove Pharma Sign Distribution Agreement for AK-FLUOR

Keeler announced a collaboration with Long Grove Pharmaceuticals for the distribution of AK-FLUOR (f...

read more
Keeler and Long Grove Pharma Sign Distribution Agreement for AK-FLUOR
November 17, 2023
More